TFMB-(R)-2-HG
CAS No. 1445700-01-5
TFMB-(R)-2-HG( —— )
Catalog No. M23608 CAS No. 1445700-01-5
TFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 136 | In Stock |
|
| 5MG | 161 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 452 | In Stock |
|
| 50MG | 662 | In Stock |
|
| 100MG | 918 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTFMB-(R)-2-HG
-
NoteResearch use only, not for human use.
-
Brief DescriptionTFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
-
DescriptionTFMB-(R)-2-HG is a carcinogenic factor in Acute myeloid leukemia (AML). TFMB-(R)-2-HG impairs SCF ER-Hoxb8 cell differentiation in response to estrogen withdrawal.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCarcinogenic factor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1445700-01-5
-
Formula Weight288.22
-
Molecular FormulaC13H11F3O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:240 mg/mL (832.7 mM)
-
SMILESO=C([C@@H](CC1)OC1=O)OCC2=CC=CC(C(F)(F)F)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Losman JA, et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science. 2013 Mar 29;339(6127):1621-5.
molnova catalog
related products
-
Thymine
Thymine is found in the nucleic acid DNA. In RNA thymine is replaced with uracil in most cases. In DNA, thymine binds to adenine via two hydrogen bonds to assist in stabilizing the nucleic acid structures.
-
Astragaloside II
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
-
Mahuannin G
Mahuannin G
Cart
sales@molnova.com